A French pharmaceutical company involved in the benfluorex scandal could be sued for defrauding public and private health insurance, according to an article in Le Figaro on 5 August.
A Paris court ordered that Servier Laboratories should be investigated for fraud, in addition to the initial charge of “aggravated deception” and “homicide and unintentional injuries”, the newspaper reported.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.